Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives

dc.creatorJamebozorgi K.
dc.creatorTaghizadeh E.
dc.creatorRostami D.
dc.creatorPormasoumi H.
dc.creatorBarreto G.E.
dc.creatorHayat S.M.G.
dc.creatorSahebkar A.
dc.date.accessioned2020-09-02T22:20:41Z
dc.date.accessioned2022-11-08T20:21:42Z
dc.date.available2020-09-02T22:20:41Z
dc.date.available2022-11-08T20:21:42Z
dc.date.created2020-09-02T22:20:41Z
dc.date.issued2019
dc.identifier56, 7, 4799-4811
dc.identifier08937648
dc.identifierhttps://hdl.handle.net/20.500.12728/4965
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5144132
dc.languageen
dc.publisherHumana Press Inc.
dc.subjectGene therapy
dc.subjectl-dopa
dc.subjectMolecular mechanisms
dc.subjectParkinson’s disease
dc.subjectTransplantation therapy
dc.subject3 (3,4 dihydroxyphenyl)lactic acid
dc.subjectaromatic levo amino acid decarboxylase
dc.subjectaurantiin
dc.subjectbaicalein
dc.subjectcurcumin
dc.subjectdaidzein
dc.subjectepigallocatechin gallate
dc.subjectesculin
dc.subjectgenistein
dc.subjectginkgolide B
dc.subjectginsenoside Rb 1
dc.subjectginsenoside Rd
dc.subjectginsenoside Re
dc.subjectginsenoside Rg 1
dc.subjectguanosine triphosphate cyclohydrolase I
dc.subjecthyperin
dc.subjectisorhynchophylline
dc.subjectlevodopa
dc.subjectmagnolol
dc.subjectpuerarin
dc.subjectquercetin
dc.subjectresveratrol
dc.subjectsalvianolic acid B
dc.subjectstepholidine
dc.subjecttetramethylpyrazine
dc.subjectthymoquinone
dc.subjecttriptolide
dc.subjecttyrosine 3 monooxygenase
dc.subjectumbelliferone
dc.subjectunindexed drug
dc.subjectbiological product
dc.subjectbrain depth stimulation
dc.subjectcell therapy
dc.subjectchemogenetics
dc.subjectCRISPR-CAS9 system
dc.subjectgenetic procedures
dc.subjecthuman
dc.subjecthuman embryonic stem cell
dc.subjectimmunotherapy
dc.subjectmesencephalic tissue
dc.subjectmolecular therapy
dc.subjectmotor performance
dc.subjectnonhuman
dc.subjectnuclear reprogramming
dc.subjectoptogenetics
dc.subjectParkinson disease
dc.subjectpluripotent stem cell
dc.subjectquality of life
dc.subjectReview
dc.subjectRNAi therapeutics
dc.subjectstem cell transplantation
dc.subjecttreatment response
dc.subjectviral gene delivery system
dc.subjectanimal
dc.subjectbiological model
dc.subjectcell transplantation
dc.subjectgene editing
dc.subjectgene therapy
dc.subjectimmunology
dc.subjectParkinson disease
dc.subjectAnimals
dc.subjectBiological Products
dc.subjectCell Transplantation
dc.subjectGene Editing
dc.subjectGenetic Therapy
dc.subjectHumans
dc.subjectModels, Biological
dc.subjectParkinson Disease
dc.titleCellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives
dc.typeReview


Este ítem pertenece a la siguiente institución